Interventions into the degenerative aging process are still only in their infancy.
I have just returned from the first Monod Conference on the Comparative Biology of Aging.
Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than...
Last week Len Guarente announced his company will be selling a proprietary anti-aging formula based on NR, the NADH precursor.